KEY CONSIDERATIONS FOR EVALUATING REAL-WORLD EVIDENCE IN SUPPORT OF FDA REGULATORY DECISION-MAKING

被引：0
|
作者：
Li, Jie [1 ]
机构：
[1] FDA CDER Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
INNOVATION IN AGING | 2022年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] USING REAL-WORLD EVIDENCE TO SUPPORT REIMBURSEMENT DECISION-MAKING IN CHINA: CURRENT PRACTICES, CHALLENGES AND OPPORTUNITIES
    Liu, J.
    Feng, Y.
    Yang, S.
    Yin, Z.
    Xie, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S141 - S141
  • [32] Support vector machine with fuzzy decision-making for real-world data classification
    Li, Boyang
    Hu, Jinglu
    Hirasawa, Kotaro
    Sun, Pu
    Marko, Kenneth
    2006 IEEE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORK PROCEEDINGS, VOLS 1-10, 2006, : 587 - +
  • [33] Real-world evidence enhances decision making
    Malone, Daniel C.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (12): : 1612 - 1614
  • [34] Study Design Considerations for Real-world Observational Studies Supporting Pre-Approval Regulatory Decision-making in China
    Song, Yufei
    Li, Jiang
    Li, Ziyi
    Ban, Lu
    Rouleau, Alice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 553 - 553
  • [35] Leveraging Real-World Evidence Derived from Patient Registries for Premarket Medical Device Regulatory Decision-Making
    Yue, Lilly Q.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2018, 10 (02): : 98 - 103
  • [36] THE USE OF REAL-WORLD EVIDENCE IN FDA REGULATORY SUBMISSIONS: A REVIEW
    Raina, N.
    Ko, J.
    VALUE IN HEALTH, 2023, 26 (06) : S381 - S381
  • [37] REAL-WORLD EVIDENCE IN MULTIPLE SCLEROSIS (MS): HTA DECISION-MAKING INFLUENCER OR NOT?
    Nanda, S.
    Jindal, S.
    Rohillla, A.
    Mahajan, S.
    Saharia, P.
    VALUE IN HEALTH, 2022, 25 (12) : S344 - S344
  • [38] Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
    Alnofal, Fatemah A.
    Alrwisan, Adel A.
    Alshammari, Thamir M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1303 - 1306
  • [39] Lessons for regulatory decision-making from real-world data trial emulation results
    Wang, Shirley
    Schneeweiss, Sebastian
    Crown, William
    Ross, Joseph
    Arlett, Peter
    Quinto, Kenneth
    Uyama, Yoshiaki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 8 - 8
  • [40] Die Anwendung von Real-world-Evidenz in Entscheidungsprozessen der ArzneimittelregulationThe application of real-world evidence in drug regulatory decision-making
    Julia Wicherski
    Britta Haenisch
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2024, 67 (2) : 149 - 154
12345